MedTrace Logo

Continuous Monitoring of Vital Parameters for Early Detection of Clinical Deterioration in Hospitalized Patients

NCT04305262 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2022-01-21

No results posted yet for this study

Summary

For patients admitted to the medical ward, it is often difficult to predict if their clinical condition will deteriorate, however subtle changes in vital signs are usually present 8 to 24 hours before a life-threatening event such as respiratory failure leading to ICU admission, or unanticipated cardiac arrest. Such adverse trends in clinical observations can be missed, misinterpreted or not appreciated as urgent. New continuous and wearable 24/7 clinical vital parameter monitoring systems offer a unique possibility to identify clinical deterioration before patients condition progress beyond the point-of-no-return, where adverse events are inevitable. The WARD project aims to determine the correlation between cardiopulmonary micro events and clinical adverse events during the first four days after hospital admission.

Conditions

  • Continuous Wireless Vital Parameter Monitoring

Interventions

DEVICE

Wireless continuous vital parameter monitoring

The patients included in this study will have continuous, wireless monitoring of vital parameters during the first four days of acute admission

Sponsors & Collaborators

  • Technical University of Denmark

    collaborator OTHER

  • Bispebjerg Hospital

    collaborator OTHER

  • Rigshospitalet, Denmark

    collaborator OTHER

  • University Hospital Bispebjerg and Frederiksberg

    lead OTHER

Principal Investigators

  • Christian Meyhoff, MD, PhD · Bispebjerg Hospital

  • Katja Grønbæk, MD · Bispebjerg Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-25
Primary Completion
2020-08-01
Completion
2020-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04305262 on ClinicalTrials.gov